Corundum Group, Inc. Abb Vie Inc. Transaction History

Corundum Group, Inc.

$218 Million
Q3 2024

A detailed history of Corundum Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Corundum Group, Inc. holds 5,022 shares of ABBV stock, worth $880,758. This represents 0.45% of its overall portfolio holdings.

Number of Shares

5,022

Previous 9,233 45.61%

Holding current value

$880,758

Previous $1.58 Million 37.4%

% of portfolio

0.45%

Previous 0.62%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$163.84 - $199.33 $689,930 - $839,378	-4,211 Reduced 45.61%	5,022 $991,000
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $675,967 - $789,378	4,367 Added 89.75%	9,233 $1.58 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $16,301 - $18,574	-102 Reduced 2.05%	4,866 $886,000
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $14,585 - $16,426	106 Added 2.18%	4,968 $769,000
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $116,624 - $135,009	-873 Reduced 15.22%	4,862 $724,000
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $569,130 - $708,245	-4,295 Reduced 42.82%	5,735 $772,000
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $509,894 - $587,220	3,526 Added 54.21%	10,030 $1.6 Million
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $16,597 - $19,904	120 Added 1.88%	6,504 $1.05 Million
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $120,520 - $138,229	898 Added 16.37%	6,384 $857,000
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $13,762 - $17,496	100 Added 1.86%	5,486 $840,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $18,873 - $23,416	143 Added 2.73%	5,386 $873,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $58,764 - $74,353	547 Added 11.65%	5,243 $710,000
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $51,923 - $58,940	488 Added 11.6%	4,696 $507,000
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $5,996 - $6,680	57 Added 1.37%	4,208 $474,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $8,900 - $9,797	87 Added 2.14%	4,151 $449,000
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $26,159 - $35,317	325 Added 8.69%	4,064 $435,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $321,217 - $377,003	3,739 New	3,739 $327,000
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $301,372 - $353,711	-3,508 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $257,381 - $344,415	3,508 New	3,508 $344,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.

Account

Corundum Group, Inc. Abb Vie Inc. Transaction History